pyrazinamide has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Chemical and Drug Induced Liver Injury, Chronic: Liver disease lasting six months or more, caused by an adverse effect of a drug or chemical. The adverse effect may be caused by drugs, drug metabolites, chemicals from the environment, or an idiosyncratic response.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Wen, Y | 1 |
Zhang, G | 1 |
Wu, X | 1 |
Ezhilarasan, D | 1 |
1 review available for pyrazinamide and Chemical and Drug Induced Liver Injury, Chronic
Article | Year |
---|---|
Antitubercular drugs induced liver injury: an updated insight into molecular mechanisms.
Topics: Antitubercular Agents; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injur | 2023 |
1 other study available for pyrazinamide and Chemical and Drug Induced Liver Injury, Chronic
Article | Year |
---|---|
The role of the farnesoid X receptor in quadruple anti-tuberculosis drug-induced liver injury.
Topics: Animals; Antitubercular Agents; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Chemic | 2022 |